|Top Biopolitical Times Posts of 2014, Biopolitical TimesDecember 18th, 2014In 2014, CGS staffers and contributors posted 107 blogs in Biopolitical Times. These are 12 of our favorites.|
|Are All Pluripotent Stem Cells Equal?, Biopolitical TimesNovember 12th, 2014A new paper by long-term advocates of research cloning implies that it has no advantage over reprogramming cells.|
|Stem Cell Treatments Surging Into Clinic, UT San DiegoOctober 7th, 2014How the government, insurers and patients would pay for very expensive new stem cell therapies drew the attention of more than 700 biomedical and health-care executives at the 2014 Stem Cell Meeting on the Mesa. |
|Hwang Woo-suk Reaches the Silver Screen, Biopolitical TimesOctober 2nd, 2014A new movie opening in Korea is explicitly about how the notorious cloning and stem-cell fraud was revealed, though the names of the principals have been changed.|
|Stem cell therapy a primitive art, Financial ReviewAugust 27th, 2014A loophole in Australian regulations means people can be given stem cell therapy for virtually anything, providing their own stem cells are harvested and then used in the process. But much can go wrong.|
|On Meta-Research and the STAP Fiasco, Biopolitical TimesJuly 7th, 2014The authors of the ballyhooed STAP papers have reluctantly agreed to retract them; meanwhile Stanford is launching a project to investigate the process of research.|
|Banking on iPSCs, The ScientistJune 30th, 2014A flurry of induced pluripotent stem cell banks are coming online, but they face significant business challenges.|
|Selling Stem Cells Honestly, Biopolitical TimesJune 25th, 2014Scientists around the world are campaigning in favor of sensible regulation of stem-cell therapies. It’s about time.|
|Stem Cells in Sports Medicine, Biopolitical TimesMay 29th, 2014The use of adult stem cells in sports medicine is growing, although the evidence that they help post-operative recovery is anecdotal.|
|Scientists, Stem Cells and Self-Delusion?, Biopolitical TimesMay 10th, 2014A very disquieting meta-analysis casts doubt on recent findings suggesting that bone marrow stem cells can help in treating heart disease.|
|Transcendence: See it for its Cultural Relevance, Not its Plot Line, Biopolitical TimesMay 1st, 2014Transcendence won’t win you over with its dialogue or love scenes, but it’s a great springboard for pondering what quickly approaching developments in artificial intelligence, synthetic biology, and regenerative medicine may actually mean for society.|
|Stem Cell Revival: The 1990s are BackNew ScientistApril 30th, 2014More than 17 years later, what worked in Dolly the sheep finally appears to be working in humans. But after endless hope, hype and failure, it is hard to feel there is anything brave or new in this line of research.|
|More Cloning and Even More Eggs, Biopolitical TimesApril 30th, 2014For the third time in less than a year, human embryonic stem cells have been derived by cloning, underlining the need to establish federal prohibitions against human reproductive cloning and protections for women who provide their eggs for the research.|
|Doubts Over Heart Stem-Cell Therapy, NatureApril 29th, 2014An analysis of clinical studies that use adult stem cells to treat heart disease has raised questions about the value of a therapy that many consider inappropriately hyped.|
|Stem Cells Made by Cloning Adult Humans, NatureApril 28th, 2014Two research groups have independently produced human embryonic stem-cell lines from embryos cloned from adult cells. But the technique is expensive, technically difficult and ethically fraught.|
|New Hope for Embattled STAP Cell Researchers?, Los Angeles TimesApril 1st, 2014Just hours after Japanese investigators announced findings of fabrication and misconduct in a highly criticized "acid bath" stem cell study, scientists in Hong Kong said they had partly succeeded in reproducing the controversial experiment.|
|Hwang's Patented Fraud and |
New Questions about STAP Cells , Biopolitical TimesFebruary 19th, 2014Hwang Woo-suk is awarded a U.S. patent based on the work for which he was disgraced almost a decade ago; an investigation is launched into some apparently similar errors in the recent STAP cell papers.
|Are STAP Stem Cells a Paradigm Changer? Hopes and Fears, Biopolitical TimesFebruary 6th, 2014Two papers published in Nature on January 30 describe a new and remarkably simple technique for generating cells that can, like embryonic stem cells, develop into many different kinds of cells. |
|Cloning comeback, Nature NewsJanuary 14th, 2014Ten years ago, Woo Suk Hwang rose to the top of his field before fraud and dodgy bioethical practices derailed his career. Can a scientific pariah redeem himself? |
|Biopolitical News of the Year 2013, Biopolitical TimesDecember 19th, 2013For better and worse, 2013 has been a year in which several related issues familiar to those who follow human biotechnology moved into the wider sphere of public discussion.|
|An Insider’s Antidote for Dangerous Stem Cell Hype, XconomyOctober 22nd, 2013Paul Knoepfler’s new book is a scientific primer and a paean to the promise of stem cell research, but also a warning to vulnerable patients who prematurely look to stem cell therapy as a last-ditch hope for a cure.
|Stem Cells Created in Living Mice, NatureSeptember 11th, 2013Researchers have reprogrammed adult mouse cells to behave like embryonic stem cells that can take on a wider variety of identities, without removing those cells from their natural environment.|
|Stem Cell Treatments Overtake Science, The New York TimesSeptember 9th, 2013The lack of proven safety or efficacy for stem cell treatments hasn't slowed the rise of an international industry catering to customers who may pay tens of thousands of dollars in cash for their shot at a personal miracle. |
|Scientists Grow Mini Brains From Stem Cells, CNNAugust 29th, 2013Scientists have used stem cells to create what they are calling "cerebral organoids" - pea-sized structures made of human brain tissue that may help explore brain development and disorders.|
|Stem Cells: Egg Engineers, NatureAugust 21st, 2013In a technical tour de force, Japanese researchers created eggs and sperm in the laboratory. Now, scientists have to determine how to use those cells safely — and ethically.|
|A Lab-Grown Burger Gets a Taste Test, The New York TimesAugust 5th, 2013A hamburger made from bovine stem cells was fried, served and eaten in London in an odd demonstration of one view of the future of food. The $325,000 project was paid for by Google founder Sergey Brin.|
|A Few Notes on the InvisibleJuly 23rd, 2013Thoughts about disability, invisibility, Ethan Saylor's death at the hands of private police, and news that the extra chromosome that causes Down syndrome may one day be “silenced.”|
|Controversial Korean Stem Cell Powerhouse in Big Trouble?, Biopolitical TimesJuly 22nd, 2013RNL Bio, the controversial Korean biotechnology company, is undergoing some major changes. Its former CEO is under arrest for insider trading, its subsidiaries are going bust and the parent company is being delisted from the stock exchange. But it's still relying on the stem cell business to pull it through.|
|Stem Cells Reprogrammed Using Chemicals Alone, NatureJuly 18th, 2013Scientists have demonstrated a new way to reprogram adult tissue to become cells as versatile as embryonic stem cells without the addition of extra genes that could increase the risk of dangerous mutations.|
|Trial and Error, NatureJuly 9th, 2013Italian officials should not go ahead with expensive clinical tests of an unproven stem-cell therapy that has no good scientific basis.|
|Japan to Relax Ban on Chimeric Embryo Experiments, ScienceJune 19th, 2013A scientist pioneering research toward generating human organs in pigs has cleared one hurdle in Japan, but is concerned that finalizing guidelines will take too long, so is considering conducting key experiments in the United States.|
|Cloning for Stem Cells: Controversy, Again, Biopolitical TimesMay 30th, 2013Errors have been found and acknowledged in the recent paper on the creation of stem cells through cloning – a reminder that questions about the utility and risks of research cloning go deeper than “careless” duplication of images.|
|Back to the Future: Cloning Human Stem Cells [VIDEO]Al JazeeraMay 17th, 2013Three commentators, including a scientist who previously supported research cloning, agree that the availability of less controversial alternatives for producing disease-specific and patient-specific stem cells makes this approach unnecessary.|
|Cloning, Stem Cells Long Mired In Legislative Gridlock[Quotes CGS's Marcy Darnovsky], NPRMay 16th, 2013The news that U.S. scientists have successfully cloned a human embryo seems almost certain to rekindle a political fight that has raged, on and off, since the announcement of the creation of Dolly the sheep in 1997.|
|Critiquing the Stem Cell Board[Editorial]Los Angeles TimesFebruary 27th, 2013California's stem cell institute is finally making some changes, but the modifications are more a bandage than a cure. Like a bandage, they will probably do, but only for a limited time.|
|Billionaires Anoint Biogeeks, ForbesFebruary 20th, 2013A group of Silicon Valley billionaires announced awards of $3 million to each of eleven recipients, in the first round of their "Breakthrough Prize in Life Sciences."|
|Moore is LessWhy the Development of Pluripotent Stem Cells Might Lead Us to Rethink Differential Property Interests in Excised Human Cells, Stanford Technology Law ReviewJanuary 15th, 2013A proposal for addressing the profound legal issues raised by induced pluripotent stem cells.|
|Safety of Induced Stem Cells Gets a Boost, NatureJanuary 9th, 2013A new paper could renew hopes of turning a patient’s own cells into perfectly matched replacement tissues, though differences in methodology between the study and clinical practice have left some eager for more proof.|
|RNL Bio Smuggled Out Stem Cells, The Korea TimesJanuary 3rd, 2013RNL Bio sent 15.5 billion won worth of stem cells to hospitals in China and Japan on 860 different occasions from November 2008 through July 2012 without reporting the shipments.|
|Stem Cell Controversy #1: Celltex and the FDA, Biopolitical TimesOctober 18th, 2012The FDA has warned Texas stem-cell treatment company Celltex, and the review board that approved its activities, that the company is illegally selling an unlicensed drug and violates good manufacturing practices.|
|Stem-Cell Fraud Hits Febrile Field, NatureOctober 16th, 2012As Hisashi Moriguchi's heart-treatment claims collapse, observers warn about the febrile nature of the iPS-cell field and caution against a rush to the clinic.
|The HealerHow Shinya Yamanaka Transformed the Stem-Cell War and Made Everyone a Winner, SlateOctober 9th, 2012Shinya Yamanaka's research on "induced pluripotent stem cells" earned him a Nobel Prize. But much of the media coverage missed half the story. Yamanaka’s venture wasn’t just an experiment. It was a moral project.|
|Sperm Precursor Cells Created in Lab, BioEdgeSeptember 7th, 2012Scientists may soon be able to create artificial sperm from a skin cell. Proponents extol benefits for sterile men; opponents warn of future obsolescence of males.|
|Patients Seek Stem-Cell Compensation, Nature NewsJuly 6th, 2012Six patients in California are suing RNL Bio, one of the world’s largest stem-cell companies, for allegedly misleading them about the effectiveness of its stem-cell treatments.|
|Will the FDA Close Down Celltex?
, Biopolitical TimesJune 28th, 2012An FDA report itemizes 79 specific problems with the Texas stem-cell company Celltex, and more trouble may be on the way.
|More Scandals in South Korea, Biopolitical TimesJune 8th, 2012Fresh accusations of stem-cell fraud, whose full extent is yet unknown, are rocking South Korea and threatening to damage the nation's reputation again. |
|California Considers DNA Privacy Law, NatureMay 18th, 2012California lawmakers are considering a bill that would require written consent for the collection, retention, and sharing of individual genetic information. Academic researchers fear the measures would prohibit work with genetic databases.
|Stem Cell Fraud Is the Real Issue in Texas, Biopolitical TimesMarch 2nd, 2012Bioethicist Glenn McGee has resigned from Celltex. His connection with the controversial stem-cell company has raised important issues about its business practices.|
|Rick Perry, Glenn McGee and Selling Texas Stem Cells, Biopolitical TimesFebruary 16th, 2012Gov. Perry is actively promoting an industry based on adult stem cells, in which Glenn McGee, until recently editor of the American Journal of Bioethics, is now employed. |
|Stem Cell Banking: The Newest Lure in Medical TourismArab princes and U.S. celebrities fly in for futuristic bio-care at Seoul "Life Center" , CNNFebruary 2nd, 2012In a new form of medical tourism, people from around the world are traveling to Seoul for stem cell treatments and to bank their stem cells, hoping that this will one day save their lives. |
|Geron Quits the Embryonic Stem Cell Industry, Biopolitical TimesNovember 16th, 2011Geron has cancelled its clinical trial of a stem-cell treatment for spinal cord injuries, raising questions about the future of the company and the industry.|
|Hwang Clones Coyotes, Scores Headlines, Biopolitical TimesOctober 19th, 2011Disgraced South Korean scientist Hwang Woo-Suk continues his efforts at rehabilitation by cloning endangered coyotes.|
|More on Cash for Eggs, Biopolitical TimesOctober 13th, 2011The Nuffield Council on Bioethics has issued a report about the provision of human bodily material for medicine and for research, including the issue of payment for gametes.|
|High-interest clones[Editorial]NatureOctober 6th, 2011Research into cloned human cells has left the specter of past scientific fraud behind. But reaction to the earlier work still holds worthwhile lessons.
|New Chair for California Stem Cell Agency, Biopolitical TimesJune 29th, 2011By a narrow margin, the CIRM board elected financier Jonathan Thomas as Chair, provoking significant criticism over his huge salary.|
|Setback for New Stem Cell Treatment, The New York TimesMay 13th, 2011Researchers reported on Friday that tissues made from induced pluripotent stem cells might be rejected by a patient’s immune system — even though the tissues would be derived from the same patient.|
|Stem Cell Strife in US and EU Courts, Biopolitical TimesMay 11th, 2011Developments in US and European courts regarding funding and oversight of stem cell research have reopened passionate debates.
|Bioethicists Show How to Disagree Without Rancor, Biopolitical TimesApril 19th, 2011Excerpts of a conversation between Arthur Caplan and Robert P. George demonstrate the possibility of constructive discussions about difficult ethical issues.|